| [1] | Bundhamcharoen K, Odton P, Phulkerd S, Tangcharoensathien V (2011) Burden of disease in Thailand: changes in health gap between 1999 and 2004. BMC Public Health 11: 53. doi: 10.1186/1471-2458-11-53. pmid:21266087
|
| [2] | Sripa B, Pairojkul C (2008) Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24: 349–356. doi: 10.1097/MOG.0b013e3282fbf9b3. pmid:18408464
|
| [3] | Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, et al. (2011) Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 120 Suppl 1: S158–168. doi: 10.1016/j.actatropica.2010.07.006. pmid:20655862
|
| [4] | Khuntikeo N, Chamadol N, Yongvanit P, Loilome W, Namwat N, et al. (2015) Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 15: 459. doi: 10.1186/s12885-015-1475-7. pmid:26054405
|
| [5] | Grundy-Warr C, Andrews RH, Sithithaworn P, Petney TN, Sripa B, et al. (2012) Raw attitudes, wetland cultures, life-cycles: socio-cultural dynamics relating to Opisthorchis viverrini in the Mekong Basin. Parasitol Int 61: 65–70. doi: 10.1016/j.parint.2011.06.015. pmid:21712097
|
| [6] | IARC (2012) A Review of Human Carcinogens: Opisthorchis viverrini and Clonorchis sinensis. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 100B: 341–370.
|
| [7] | Chamadol N, Pairojkul C, Khuntikeo N, Laopaiboon V, Loilome W, et al. (2014) Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J Hepatobiliary Pancreat Sci 21: 316–322. doi: 10.1002/jhbp.64. pmid:24420706
|
| [8] | Elkins DB, Haswell-Elkins MR, Mairiang E, Mairiang P, Sithithaworn P, et al. (1990) A high frequency of hepatobiliary disease and suspected cholangiocarcinoma associated with heavy Opisthorchis viverrini infection in a small community in north-east Thailand. Trans R Soc Trop Med Hyg 84: 715–719. pmid:2177578 doi: 10.1016/0035-9203(90)90159-c
|
| [9] | Sithithaworn P, Yongvanit P, Duenngai K, Kiatsopit N, Pairojkul C (2014) Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21: 301–308. doi: 10.1002/jhbp.62. pmid:24408775
|
| [10] | Yongvanit P, Pinlaor S, Bartsch H (2012) Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int 61: 130–135. doi: 10.1016/j.parint.2011.06.011. pmid:21704729
|
| [11] | Miwa M, Honjo S, You G, Tanaka M, Uchida K, et al. (2014) Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. World J Gastrointest Pathophysiol 5: 570–578. doi: 10.4291/wjgp.v5.i4.570. pmid:25401000
|
| [12] | Songserm N, Promthet S, Sithithaworn P, Pientong C, Ekalaksananan T, et al. (2012) Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol 36: e89–94. doi: 10.1016/j.canep.2011.11.007. pmid:22189445
|
| [13] | Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, et al. (2012) Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford) 14: 177–184. doi: 10.1111/j.1477-2574.2011.00423.x
|
| [14] | Thinkhamrop K, Khuntikeo N, Phonjitt P, Chamadol N, Thinkhamrop B, et al. (2015) Association between Diabetes Mellitus and Fatty Liver Based on Ultrasonography Screening in the World's Highest Cholangiocarcinoma Incidence Region, Northeast Thailand. Asian Pac J Cancer Prev 16: 3931–3936. pmid:25987063 doi: 10.7314/apjcp.2015.16.9.3931
|
| [15] | IARC (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61: 1–241. pmid:7715068. doi: 10.1002/ijc.2910600502
|
| [16] | Jongsuksuntigul P, Imsomboon T (2003) Opisthorchiasis control in Thailand. Acta Trop 88: 229–232. pmid:14611877 doi: 10.1016/j.actatropica.2003.01.002
|
| [17] | Sadun EH (1955) Studies on Opisthorchis viverrini in Thailand. Am J Hyg 62: 81–115. pmid:13258561
|
| [18] | Brockelman WY, Upatham ES, Viyanant V, Hirunraks A (1987) Measurement of incidence of the human liver fluke, Opisthorchis viverrini, in northeast Thailand. Trans R Soc Trop Med Hyg 81: 327–335. pmid:3617199 doi: 10.1016/0035-9203(87)90255-0
|
| [19] | Khampitak T, Knowles J, Yongvanit P, Sithithaworn P, Tangrassameeprasert R, et al. (2006) Thiamine deficiency and parasitic infection in rural Thai children. Southeast Asian J Trop Med Public Health 37: 441–445. pmid:17120961
|
| [20] | Sripa B, Tangkawattana S, Laha T, Kaewkes S, Mallory FF, et al. (2015) Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project. Acta Trop 141: 361–367. doi: 10.1016/j.actatropica.2014.07.017. pmid:25102053
|
| [21] | Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, et al. (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4: e201. pmid:17622191 doi: 10.1371/journal.pmed.0040201
|
| [22] | Saengsawang P, Promthet S, Bradshaw P (2012) Prevalence of OV infection in Yasothon Province, Northeast Thailand. Asian Pac J Cancer Prev 13: 3399–3402. pmid:22994767 doi: 10.7314/apjcp.2012.13.7.3399
|
| [23] | Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, et al. (2012) The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int 61: 10–16. doi: 10.1016/j.parint.2011.08.014. pmid:21893213
|
| [24] | Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, et al. (2004) Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 9: 588–594. pmid:15117303 doi: 10.1111/j.1365-3156.2004.01234.x
|
| [25] | National Cancer Institute DoMS, Ministry of Public Health, Thailand (2009) Hospital-Based Cancer Registry. Annual Report 42–43.
|
| [26] | National Cancer Institute DoMS, Ministry of Public Health, Thailand (2012) Hospital-Based Cancer Registry. Annual Report 47–48.
|
| [27] | Saengsawang P, Promthet S, Bradshaw P (2013) Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand. Asian Pac J Cancer Prev 14: 2963–2966. pmid:23803062 doi: 10.7314/apjcp.2013.14.5.2963
|
| [28] | Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383: 2168–2179. doi: 10.1016/S0140-6736(13)61903-0. pmid:24581682
|
| [29] | Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, et al. (2012) Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 61: 1657–1669. doi: 10.1136/gutjnl-2011-301748. pmid:22895392
|
| [30] | Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45: 856–867. pmid:17030071 doi: 10.1016/j.jhep.2006.09.001
|
| [31] | Sriputtha S, Khuntikeo N, Promthet S, Kamsa-Ard S (2013) Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev 14: 1107–1110. pmid:23621195 doi: 10.7314/apjcp.2013.14.2.1107
|
| [32] | Pattanathien P, Khuntikeo N, Promthet S, Kamsa-Ard S (2013) Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev 14: 321–324. pmid:23534746 doi: 10.7314/apjcp.2013.14.1.321
|
| [33] | Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, et al. (2012) Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol 38: 1197–1203. doi: 10.1016/j.ejso.2012.08.009. pmid:22992326
|
| [34] | Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, et al. (2013) Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 258: 129–140. doi: 10.1097/SLA.0b013e3182708b57. pmid:23059502
|
| [35] | Kamsa-ard S, Wiangnon S, Suwanrungruang K, Promthet S, Khuntikeo N, et al. (2011) Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev 12: 2209–2213. pmid:22296358 doi: 10.7314/apjcp.2012.13.3.1065
|
| [36] | Khuntikeo N, Pugkhem A, Titapun A, Bhudhisawasdi V (2014) Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience. J Hepatobiliary Pancreat Sci 21: 521–524. doi: 10.1002/jhbp.74. pmid:24464976
|
| [37] | Pungpak S, Sornmani S, Suntharasamai P, Vivatanasesth P (1989) Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel. Southeast Asian J Trop Med Public Health 20: 157–162. pmid:2672363
|
| [38] | Mairiang E, Elkins DB, Mairiang P, Chaiyakum J, Chamadol N, et al. (1992) Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography. J Gastroenterol Hepatol 7: 17–21. pmid:1311966 doi: 10.1111/j.1440-1746.1992.tb00928.x
|
| [39] | Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, et al. (1996) Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 171: 147–152; discussion 152–143. pmid:8554130 doi: 10.1016/s0002-9610(99)80090-7
|
| [40] | Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, et al. (1993) Diagnostic role of serum CA 19–9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68: 874–879. pmid:8396700 doi: 10.1016/0270-9139(94)90038-8
|
| [41] | Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ (2000) The utility of CA 19–9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 95: 204–207. pmid:10638584 doi: 10.1111/j.1572-0241.2000.01685.x
|
| [42] | Bjornsson E, Kilander A, Olsson R (1999) CA 19–9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 19: 501–508. pmid:10661684 doi: 10.1111/j.1478-3231.1999.tb00083.x
|
| [43] | Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R (1995) Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108: 865–869. pmid:7875490 doi: 10.1016/0016-5085(95)90462-x
|
| [44] | Yongvanit P, Pinlaor S, Loilome W (2014) Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21: 309–315. doi: 10.1002/jhbp.63. pmid:24408859
|
| [45] | Silsirivanit A, Sawanyawisuth K, Riggins GJ, Wongkham C (2014) Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches. J Hepatobiliary Pancreat Sci 21: 388–396. doi: 10.1002/jhbp.68. pmid:24616382
|
| [46] | Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57–70. pmid:10647931 doi: 10.1016/s0092-8674(00)81683-9
|
| [47] | Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646–674. doi: 10.1016/j.cell.2011.02.013. pmid:21376230
|
| [48] | Krause DS, Van Etten RA (2005) Tyrosine kinases as targets for cancer therapy. N Engl J Med 353: 172–187. pmid:16014887 doi: 10.1056/nejmra044389
|
| [49] | Ross JS, Schenkein DP, Pietrusko R, Rolfe M, Linette GP, et al. (2004) Targeted therapies for cancer 2004. Am J Clin Pathol 122: 598–609. pmid:15487459 doi: 10.1309/5cwpu41afr1vym3f
|
| [50] | Vaeteewoottacharn K, Seubwai W, Bhudhisawasdi V, Okada S, Wongkham S (2014) Potential targeted therapy for liver fluke associated cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21: 362–370. doi: 10.1002/jhbp.65. pmid:24408866
|
| [51] | Worasith C, Kamamia C, Yakovleva A, Duenngai K, Wangboon C, et al. (2015) Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. PLoS Negl Trop Dis 9: e0004157. doi: 10.1371/journal.pntd.0004157. pmid:26485024
|
